Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Otamixaban for use in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting

US Patent 9597322 · Granted Mar 21, 2017

Estimated economic value: $7,741,000

Assignee

Inventors

View full patent text on Google Patents →